✦ LIBER ✦

76 Clinical and immunological monitoring of a multi-peptide vaccination trial in patients with stage III renal cell carcinoma

✍ Scribed by J. Bedke; K. Laske; S. Feyerabend; C. Gouttefangeas; A. Dröge; J. Hennelotter; P. Hrstić; S. Stevanović; H.G. Rammensee; A. Stenzl

Book ID: 119624013
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 51 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(12)60075-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

246 SPECIFIC CD4+ AND CD8+ T CELLS ACTIV

246 SPECIFIC CD4+ AND CD8+ T CELLS ACTIVATION BY MULTI-PEPTIDE VACCINATION IN PATIENTS WITH STAGE III RENAL CELL CARCINOMA

✍ Bedke, Jens; Laske, Karoline; Gouttefangeas, Cécile; Feyerabend, Susan; Hennenlo 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB

Immunogenecity of G250 peptides: rationa

Immunogenecity of G250 peptides: rationale for a dendritic cell peptide vaccine trial in patients with advanced renal cell carcinoma

✍ Ivar Bleumer; Dorien Tiemessen; Jeanette Oosterwijk-Wakka; Wim Jongmans; Pieter 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 184 KB

Renal cell carcinoma in patients withend

Renal cell carcinoma in patients withend-stage renal disease: A comparison of clinical significance in patients receiving hemodialysis and those with renal transplants

✍ John C. Pope; Michael O. Koch; Raymond E. Bluth 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Adjuvant autologous renal tumour cell va

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

✍ Dieter Jocham; Axel Richter; Lothar Hoffmann; Klaus Iwig; Dirk Fahlenkamp; Günth 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 103 KB

429 Adjuvant vaccination in patients wit

429 Adjuvant vaccination in patients with renal cell carcinoma following radical nephrectomy is effective: Final results of a multicentre phase-III trial

✍ C. Doehn; A. Richter; W. Lehmacher; D. Jocham 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Immunological monitoring of regulatory T

Immunological monitoring of regulatory T cells by flow cytometry in a novel HLA Class II HER2/neu peptide vaccine clinical trial in breast cancer patients

✍ Matthew T. Hueman; Steven Khoo; Catherine Storrer; Katie Harris; Yusuf Jama; Cra 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB